PPARGC1A and Alzheimer disease: Levels of PGC-1α are decreased in Alzheimer’s disease (AD) and this is related to the formation of ß-amyloid plaques and greater deposition of this substance (main characteristics of AD) (Wu et al., 2006; Quin et al., 2009).